Resolving quandaries: Basaloid adenoid cystic carcinoma or breast cylindroma? The role of massively parallel sequencing

Histopathology

Volumn 68, Issue 2, 2016, Pages 262-271

  Fusco, Nicola ^a,b   Colombo, Pierre Emmanuel ^c   Martelotto, Luciano G ^a   De Filippo, Maria R ^a   Piscuoglio, Salvatore ^a   Ng, Charlotte K Y ^a   Lim, Raymond S ^a   Jacot, William ^c   Vincent Salomon, Anne ^d   Reis Filho, Jorge S ^a   Weigelt, Britta ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c CENTRE VAL D AURELLE   (France)

^d INSTITUT CURIE   (France)

Author keywords

Adenoid cystic carcinoma; Breast cancer; Cylindroma; Fluorescence in situ hybridization; Massively parallel sequencing

Indexed keywords

ADENOID CYSTIC CARCINOMA; AGED; ALLELE; ARTICLE; BASALOID ADENOID CYSTIC CARCINOMA; BENIGN TUMOR; BREAST CANCER; BREAST CYLINDROMA; BREAST TUMOR; CASE REPORT; EXOME; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MASSIVELY PARALLEL SEQUENCING; MYB NFIB GENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEGMENTAL MASTECTOMY; SEQUENCE ANALYSIS; BREAST; DNA SEQUENCE; GENETICS; HIGH THROUGHPUT SEQUENCING; METABOLISM; PARTIAL MASTECTOMY; PATHOLOGY; PHENOTYPE;

TUMOR MARKER;

AGED; BIOMARKERS, TUMOR; BREAST; BREAST NEOPLASMS; CARCINOMA, ADENOID CYSTIC; EXOME; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MASTECTOMY, SEGMENTAL; PHENOTYPE; SEQUENCE ANALYSIS, DNA;

EID: 84955197830     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12735     Document Type: Article

References (37)

1. Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ. World Health Organization classification of tumours of the breast. 4th ed. Lyon: IARC Press, 2012.
2. Foschini MP, Eusebi V. Rare (new) entities of the breast and medullary carcinoma. Pathology 2009; 41; 48-56.
3. D'Alfonso TM, Mosquera JM, MacDonald TY et al. MYB-NFIB gene fusion in adenoid cystic carcinoma of the breast with special focus paid to the solid variant with basaloid features. Hum. Pathol. 2014; 45; 2270-2280.
4. Marchio C, Weigelt B, Reis-Filho JS. Adenoid cystic carcinomas of the breast and salivary glands (or 'the strange case of Dr Jekyll and Mr Hyde' of exocrine gland carcinomas). J. Clin. Pathol. 2010; 63; 220-228.
5. Wetterskog D, Lopez-Garcia MA, Lambros MB et al. Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers. J. Pathol. 2012; 226; 84-96.
6. Wetterskog D, Wilkerson PM, Rodrigues DN et al. Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the ras pathway, but no Kit mutations. Histopathology 2013; 62; 543-550.
7. Shin SJ, Rosen PP. Solid variant of mammary adenoid cystic carcinoma with basaloid features: a study of nine cases. Am. J. Surg. Pathol. 2002; 26; 413-420.
8. Brill LB II, Kanner WA, Fehr A et al. Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms. Mod. Pathol. 2011; 24; 1169-1176.
9. Persson M, Andren Y, Mark J, Horlings HM, Persson F, Stenman G. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc. Natl Acad. Sci. USA 2009; 106; 18740-18744.
10. Gokaslan ST, Carlile B, Dudak M, Albores-Saavedra J. Solitary cylindroma (dermal analog tumor) of the breast: a previously undescribed neoplasm at this site. Am. J. Surg. Pathol. 2001; 25; 823-826.
11. Nonaka D, Rosai J, Spagnolo D, Fiaccavento S, Bisceglia M. Cylindroma of the breast of skin adnexal type: a study of 4 cases. Am. J. Surg. Pathol. 2004; 28; 1070-1075.
12. Wang N, Leeming R, Abdul-Karim FW. Fine needle aspiration cytology of breast cylindroma in a woman with familial cylindromatosis: a case report. Acta Cytol. 2004; 48; 853-858.
13. Albores-Saavedra J, Heard SC, McLaren B, Kamino H, Witkiewicz AK. Cylindroma (dermal analog tumor) of the breast: a comparison with cylindroma of the skin and adenoid cystic carcinoma of the breast. Am. J. Clin. Pathol. 2005; 123; 866-873.
14. Mahmoud A, Hill DH, O'Sullivan MJ, Bennett MW. Cylindroma of the breast: a case report and review of the literature. Diagn. Pathol. 2009; 4; 30.
15. Aggarwal R, Gupta O, Yadav YK, Dogra S. Cylindroma of the breast: a rare case report. Int. J. Trichology 2013; 5; 83-85.
16. LeBoit PE, Burg G, Weedon D, Sarasain A. World Health Organization classification of tumours. Pathology and genetics of skin tumours. Lyon: IARC Press, 2006.
17. Bignell GR, Warren W, Seal S et al. Identification of the familial cylindromatosis tumour-suppressor gene. Nat. Genet. 2000; 25; 160-165.
18. Leonard N, Chaggar R, Jones C, Takahashi M, Nikitopoulou A, Lakhani SR. Loss of heterozygosity at cylindromatosis gene locus, CYLD, in sporadic skin adnexal tumours. J. Clin. Pathol. 2001; 54; 689-692.
19. Fehr A, Kovacs A, Loning T, Frierson H Jr, van den Oord J, Stenman G. The MYB-NFIB gene fusion - a novel genetic link between adenoid cystic carcinoma and dermal cylindroma. J. Pathol. 2011; 224; 322-327.
20. Weigelt B, Horlings HM, Kreike B et al. Refinement of breast cancer classification by molecular characterization of histological special types. J. Pathol. 2008; 216; 141-150.
21. Hammond ME, Hayes DF, Dowsett M et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J. Clin. Oncol. 2010; 28; 2784-2795.
22. Wolff AC, Hammond ME, Hicks DG et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J. Clin. Oncol. 2013; 31; 3997-4013.
23. Dowsett M, Nielsen TO, A'Hern R et al. Assessment of ki67 in breast cancer: recommendations from the international ki67 in breast cancer working group. J. Natl Cancer Inst. 2011; 103; 1656-1664.
24. Ho AS, Kannan K, Roy DM et al. The mutational landscape of adenoid cystic carcinoma. Nat. Genet. 2013; 45; 791-798.
25. Lambros MB, Tan DS, Jones RL et al. Genomic profile of a secretory breast cancer with an ETV6-NTRK3 duplication. J. Clin. Pathol. 2009; 62; 604-612.
26. Weinreb I, Piscuoglio S, Martelotto LG et al. Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands. Nat. Genet. 2014; 46; 1166-1169.
27. Sathirapongsasuti JF, Lee H, Horst BA et al. Exome sequencing-based copy-number variation and loss of heterozygosity detection: Exomecnv. Bioinformatics 2011; 27; 2648-2654.
28. Boeva V, Popova T, Bleakley K et al. Control-freec: a tool for assessing copy number and allelic content using next-generation sequencing data. Bioinformatics 2012; 28; 423-425.
29. Carter SL, Cibulskis K, Helman E et al. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 2012; 30; 413-421.
30. Crisi GM, Marconi SA, Makari-Judson G, Goulart RA. Expression of c-Kit in adenoid cystic carcinoma of the breast. Am. J. Clin. Pathol. 2005; 124; 733-739.
31. Stephens PJ, Davies HR, Mitani Y et al. Whole exome sequencing of adenoid cystic carcinoma. J. Clin. Invest. 2013; 123; 2965-2968.
32. Massoumi R, Paus R. Cylindromatosis and the CYLD gene: new lessons on the molecular principles of epithelial growth control. BioEssays 2007; 29; 1203-1214.
33. van den Ouweland AM, Elfferich P, Lamping R et al. Identification of a large rearrangement in CYLD as a cause of familial cylindromatosis. Fam. Cancer 2011; 10; 127-132.
34. Daa T, Nakamura I, Yada N et al. PLAG1 and CYLD do not play a role in the tumorigenesis of adenoid cystic carcinoma. Mol. Med. Rep. 2013; 7; 1086-1090.
35. Futreal PA, Coin L, Marshall M et al. A census of human cancer genes. Nat. Rev. Cancer 2004; 4; 177-183.
36. Kandoth C, McLellan MD, Vandin F et al. Mutational landscape and significance across 12 major cancer types. Nature 2013; 502; 333-339.
37. Lawrence MS, Stojanov P, Mermel CH et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 2014; 505; 495-501.